JPH0313904B2 - - Google Patents
Info
- Publication number
- JPH0313904B2 JPH0313904B2 JP61131810A JP13181086A JPH0313904B2 JP H0313904 B2 JPH0313904 B2 JP H0313904B2 JP 61131810 A JP61131810 A JP 61131810A JP 13181086 A JP13181086 A JP 13181086A JP H0313904 B2 JPH0313904 B2 JP H0313904B2
- Authority
- JP
- Japan
- Prior art keywords
- plasma
- membrane
- blood
- separator
- isotonic solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012528 membrane Substances 0.000 claims description 68
- 210000004369 blood Anatomy 0.000 claims description 32
- 239000008280 blood Substances 0.000 claims description 32
- 239000011148 porous material Substances 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 11
- 229920005597 polymer membrane Polymers 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 description 71
- 239000000644 isotonic solution Substances 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 206010018910 Haemolysis Diseases 0.000 description 7
- 230000008588 hemolysis Effects 0.000 description 7
- 230000037452 priming Effects 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 239000012510 hollow fiber Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229920001747 Cellulose diacetate Polymers 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 108010064719 Oxyhemoglobins Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002616 plasmapheresis Methods 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61131810A JPS62290469A (ja) | 1986-06-09 | 1986-06-09 | 膜型血漿分離器 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61131810A JPS62290469A (ja) | 1986-06-09 | 1986-06-09 | 膜型血漿分離器 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62290469A JPS62290469A (ja) | 1987-12-17 |
| JPH0313904B2 true JPH0313904B2 (en]) | 1991-02-25 |
Family
ID=15066639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61131810A Granted JPS62290469A (ja) | 1986-06-09 | 1986-06-09 | 膜型血漿分離器 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62290469A (en]) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244578A (en) * | 1989-09-28 | 1993-09-14 | Terumo Kabushiki Kaisha | Blood plasma-separating membrane and blood plasma separator using the membrane |
| TWI549744B (zh) | 2012-03-28 | 2016-09-21 | 東麗股份有限公司 | 血液製劑淨化用的聚碸系中空絲膜以及中空絲膜模組 |
| JP6211000B2 (ja) | 2012-11-30 | 2017-10-11 | 東レ株式会社 | 人工保存液置換血小板溶液の製造方法 |
| CN109803748A (zh) | 2016-09-30 | 2019-05-24 | 东丽株式会社 | 培养血小板浓缩组件及使用其的血小板制剂的制造方法 |
-
1986
- 1986-06-09 JP JP61131810A patent/JPS62290469A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62290469A (ja) | 1987-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4898573A (en) | Blood components collector unit | |
| Clark et al. | Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis | |
| Reimann et al. | Plasmapheresis: technique and complications | |
| JP3664328B2 (ja) | 血漿または血清試料の調製方法 | |
| JPH05505540A (ja) | 自己血液の回収膜システム及び方法 | |
| JPH01320064A (ja) | 血液成分分離方法 | |
| Guidoin et al. | Disposable filters for microaggregate removal from extracorporeal circulation | |
| JPH0313904B2 (en]) | ||
| JP6149125B2 (ja) | 血液処理用分離膜及びこれを備える血液処理器 | |
| Mueller et al. | Poly2-methoxyethylacrylate (PMEA) coated oxygenator: an ex vivo study | |
| JPH0540585B2 (en]) | ||
| JP3088764B2 (ja) | 血液成分分離方法 | |
| Onishi et al. | Design of a new plasma separation membrane by graft copolymerization | |
| JP2000334034A (ja) | 血液成分分離方法 | |
| JP3157519B2 (ja) | 血液成分分離システム | |
| Whittlesey et al. | Is heparin necessary for extracorporeal circulation? | |
| Malchesky | 8.3 EXTRACORPOREAL ARTIFICIAL ORGANS | |
| JP2521090B2 (ja) | 血球分離装置 | |
| US20030147776A1 (en) | Filtration of red blood cells | |
| Perepechkin et al. | Hollow fibres for medical applications. A review | |
| Smith et al. | Biocompatibility of membrane plasma separators and applications for chronic hepatic assist | |
| JPH0399672A (ja) | 血漿分離方法 | |
| Pişkin | Characterization of membranes for artificial organs | |
| JPH0429409B2 (en]) | ||
| JPS6194662A (ja) | 無菌水充填血漿分離器とその製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |